The State of Content Marketing for Pharma 2026
What content marketing do pharma companies actually do?
Most pharma companies do almost no content marketing. About 9 in 10 pharma and biotech websites show no meaningful signs of it, just a brochure, an about page, a pipeline page, and a careers tab. The small remainder splits between dormant estates and a tiny active cohort, about 1 in 25, that runs content as a real system.
Why download this
- See where the industry actually sits before you plan against it
- Position your company honestly against the three maturity tiers
- Carry the numbers into board and budget conversations
What the data shows
- About 9 in 10 pharma and biotech websites show no meaningful content marketing
- Only about 1 in 25 sites run an active, structured content presence
- Even the most common format, the blog, appears on only about 1 in 17 sites
- Pricing pages exist on about 1 in 200 sites. ROI calculators and comparison pages sit close to 0 percent
- Among content producers, only about 1 in 30 assets supports post-purchase, the largest single discoverable inefficiency
How to use it
- Place your own site against the three tiers and decide which one you are actually in
- Identify your dormant estate and price what it would cost to activate it before producing anything new
- Plan one decision-stage and one post-purchase asset before the next awareness piece